These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7492766)

  • 21. The production of recombinant human erythropoietin.
    Inoue N; Takeuchi M; Ohashi H; Suzuki T
    Biotechnol Annu Rev; 1995; 1():297-313. PubMed ID: 9704092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receptor-based model accounts for phlebotomy-induced changes in erythropoietin pharmacokinetics.
    Chapel SH; Veng-Pedersen P; Schmidt RL; Widness JA
    Exp Hematol; 2001 Apr; 29(4):425-31. PubMed ID: 11301182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of the upregulation of erythropoietin-induced uptake clearance by the spleen.
    Kato M; Kato Y; Sugiyama Y
    Am J Physiol; 1999 May; 276(5):E887-95. PubMed ID: 10329983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution of the recombinant coagulation factor 125I-rFVIIa in rats.
    Beeby TL; Chasseaud LF; Taylor T; Thomsen MK
    Thromb Haemost; 1993 Sep; 70(3):465-8. PubMed ID: 8259550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of sialic acids on the pharmacokinetics of a PEGylated erythropoietin.
    Liu L; Li H; Hamilton SR; Gomathinayagam S; Rayfield WJ; van Maanen M; Yin KC; Hong L; Prueksaritanont T
    J Pharm Sci; 2012 Dec; 101(12):4414-8. PubMed ID: 22987365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of partial nephrectomy on the pharmacokinetics and pharmacodynamics of recombinant human erythropoietin (SNB-5001) in rats].
    Masunaga H; Takahira R; Kohsaka K; Sawai T
    Nihon Yakurigaku Zasshi; 1992 Apr; 99(4):205-11. PubMed ID: 1607130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in rats.
    Kato M; Okano K; Sakamoto Y; Miura K; Uchimura T; Saito K
    Arzneimittelforschung; 2001 Jan; 51(1):91-5. PubMed ID: 11215332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of a human glycoprotein (erythropoietin) produced in cultured tobacco cells.
    Matsumoto S; Ikura K; Ueda M; Sasaki R
    Plant Mol Biol; 1995 Mar; 27(6):1163-72. PubMed ID: 7766897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design of homogeneous, monopegylated erythropoietin analogs with preserved in vitro bioactivity.
    Long DL; Doherty DH; Eisenberg SP; Smith DJ; Rosendahl MS; Christensen KR; Edwards DP; Chlipala EA; Cox GN
    Exp Hematol; 2006 Jun; 34(6):697-704. PubMed ID: 16728273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative tissue distribution of 125I- and U-14C-labeled recombinant human interleukin-2 in the rat.
    Sabo J; Ni G; Nadeau R; Liberato DJ; Loh A
    Lymphokine Cytokine Res; 1992 Aug; 11(4):229-33. PubMed ID: 1420601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erythropoietin: physiologic and pharmacologic aspects.
    Fisher JW
    Proc Soc Exp Biol Med; 1997 Dec; 216(3):358-69. PubMed ID: 9402140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant human erythropoietin produced by Namalwa cells.
    Yanagi H; Yoshima T; Ogawa I; Okamoto M
    DNA; 1989; 8(6):419-27. PubMed ID: 2550193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism of erythropoietin in conscious pregnant rats.
    Gough SR; Mosher MD; Conrad KP
    Am J Physiol; 1995 May; 268(5 Pt 2):R1117-20. PubMed ID: 7771570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study on evaluating methods for the quality control of glycoprotein products. (1). Erythropoietin products].
    Kawasaki N; Morimoto K; Hayakawa T
    Eisei Shikenjo Hokoku; 1995; (113):69-73. PubMed ID: 8717231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycosylation characterization of recombinant human erythropoietin produced in glycoengineered Pichia pastoris by mass spectrometry.
    Gong B; Burnina I; Stadheim TA; Li H
    J Mass Spectrom; 2013 Dec; 48(12):1308-17. PubMed ID: 24338886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human, rat, and mouse kidney cells express functional erythropoietin receptors.
    Westenfelder C; Biddle DL; Baranowski RL
    Kidney Int; 1999 Mar; 55(3):808-20. PubMed ID: 10027918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structures of mucin-type sugar chains on human erythropoietins purified from urine and the culture medium of recombinant Chinese hamster ovary cells.
    Inoue N; Takeuchi M; Asano K; Shimizu R; Takasaki S; Kobata A
    Arch Biochem Biophys; 1993 Mar; 301(2):375-8. PubMed ID: 8460945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of the effects of altered receptor binding activity on the clearance of erythropoiesis-stimulating proteins: Nonerythropoietin receptor-mediated pathways may play a major role.
    Agoram B; Aoki K; Doshi S; Gegg C; Jang G; Molineux G; Narhi L; Elliott S
    J Pharm Sci; 2009 Jun; 98(6):2198-211. PubMed ID: 18837016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Semi-mechanistic Pharmacokinetic/Pharmacodynamic model of three pegylated rHuEPO and ior®EPOCIM in New Zealand rabbits.
    Reynaldo-Fernández G; Solozábal J; Amaro D; Fernández-Sánchez EM; Rodríguez-Vera L; Bermejo M; Mangas-Sanjuan V; Troconiz IF
    Eur J Pharm Sci; 2018 Jul; 120():123-132. PubMed ID: 29729414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The enigma of the metabolic fate of circulating erythropoietin (Epo) in view of the pharmacokinetics of the recombinant drugs rhEpo and NESP.
    Jelkmann W
    Eur J Haematol; 2002; 69(5-6):265-74. PubMed ID: 12460230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.